There might be an association between HER2 expression and TIL levels because there is solid evidence—from translational studies using tumor samples from prospective trials—that high TIL levels correlate with response to anti-HER2 therapy [29] and that patients with HER2-positive breast cancer receiving adjuvant trastuzumab showed improved survival [30]. Here, ERBB2 is linked to breast cancer.